Efficacy and tolerability of nimesulide for the treatment of migraine attacks, a randomised, double blind, placebo controlled cross-over trial
- Conditions
- migraine attacks with and without auraMedDRA version: 9.1Level: LLTClassification code 10027599Term: Migraine
- Registration Number
- EUCTR2005-000583-28-IT
- Lead Sponsor
- HELSINN HEALTHCARE SA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 162
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method